PlanVest Financial’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
PlanVest Financial's ATRA Position: Q3 2026 in Review
PlanVest Financial held its Atara Biotherapeutics (ATRA) position steady in Q3 2026 at 28 shares worth $238. The position accounts for ﹤0.01% of the portfolio, ranked #581.
PlanVest Financial first reported a position in ATRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $321 in Q2 2026. 36 funds tracked by Wall St. Rank hold ATRA as of Q3 2026.
- PlanVest Financial held 28 shares of Atara Biotherapeutics worth $238 as of Q3 2026.
- PlanVest Financial left its Atara Biotherapeutics share count unchanged in Q3 2026.
- Atara Biotherapeutics made up ﹤0.01% of PlanVest Financial's portfolio in Q3 2026, its #581 holding.
- PlanVest Financial first reported a position in Atara Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
- PlanVest Financial's Atara Biotherapeutics position peaked at $321 in Q2 2026.
- 36 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2026.
Based on PlanVest Financial's 13F filing for Q3 2026, filed 9 Nov 2026.